ZW191
Phase 1Recruiting 0 watching 0 views this week💤 Quiet
28
Development Stage
✓
Pre-clinical2
Phase 13
Phase 24
Phase 35
ApprovedIndication / Disease
Advanced Solid Tumors
Conditions
Advanced Solid Tumors
Trial Timeline
Oct 30, 2024 → Jan 1, 2027
NCT ID
NCT06555744About ZW191
ZW191 is a phase 1 stage product being developed by Zymeworks for Advanced Solid Tumors. The current trial status is recruiting. This product is registered under clinical trial identifier NCT06555744. Target conditions include Advanced Solid Tumors.
Hype Score Breakdown
Clinical
10
Activity
5
Company
5
Novelty
3
Community
2
Clinical Trials (1)
| NCT ID | Phase | Status |
|---|---|---|
| NCT06555744 | Phase 1 | Recruiting |
Competing Products
20 competing products in Advanced Solid Tumors